表否定
发表于 2025-3-25 05:36:34
http://reply.papertrans.cn/19/1812/181142/181142_21.png
营养
发表于 2025-3-25 10:55:39
Compartmental Modeling in PET Kineticspproaches for fast estimation of the kinetic parameters are introduced based on general compartmental model. The input function for the compartmental model is important for quantitative analysis of PET data, and the reference region model is one approach to avoid acquisition of the input function.
Aspirin
发表于 2025-3-25 14:54:07
http://reply.papertrans.cn/19/1812/181142/181142_23.png
grounded
发表于 2025-3-25 18:02:39
Basic Radiation Physicsts as well as mostly commonly used radiation detection and measurement devices. As this is the first chapter in the book, we made every effort to cover as many aspects that might come across the reader throughout or facilitate the understanding of other chapters.
Solace
发表于 2025-3-25 22:02:51
http://reply.papertrans.cn/19/1812/181142/181142_25.png
不可思议
发表于 2025-3-26 04:03:43
HDL in Infectious Diseases and Sepsisl techniques and the validation of analytical methods commonly employed in the quality control testing of PET radiopharmaceuticals are reported. Specific sections about the quality control of .F, .C, and .Ga radiopharmaceuticals according to EP monographs are also provided as example for the routine testing of these preparations.
Debark
发表于 2025-3-26 04:17:30
http://reply.papertrans.cn/19/1812/181142/181142_27.png
巩固
发表于 2025-3-26 12:19:44
Quality Control of PET Radiopharmaceuticalsl techniques and the validation of analytical methods commonly employed in the quality control testing of PET radiopharmaceuticals are reported. Specific sections about the quality control of .F, .C, and .Ga radiopharmaceuticals according to EP monographs are also provided as example for the routine testing of these preparations.
多产子
发表于 2025-3-26 16:13:36
HDL in Infectious Diseases and Sepsist Dossier is described, also an approach to minimise the very costly toxicological studies. The essentials of GMP and quality management systems are explained. The chapter ends with some future directions and convenient GMP approaches.
放肆的你
发表于 2025-3-26 19:47:15
https://doi.org/10.1007/978-3-319-09665-0o provides a more flexible regulatory framework for investigational PET drugs for human use produced under an investigational new drug application (IND) in accordance with part 312 and PET drugs produced with the approval of a Radioactive Drug Research Committee (RDRC) in accordance with part 361. T